Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging
The FASEB Journal · 2025
DOI: 10.1096/fj.202500128r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Yingying Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Cellular Senescence, Epithelial Cells, Kidney. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHGRI NIH HHS, DOD | AF | ATC | 59th Medical Wing (MDW).
Abstract (Originalsprache)
Renal epithelial cell senescence and kidney aging have become the focus of scientific investigation. However, how epigenetic regulation in these processes remains elusive. Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, regulates trimethylation of histone H3 at lysine 27 (H3K27me3) and plays an important role in renal pathophysiology. In this study, we show that the expression of EZH2 is decreased in naturally aged and irradiation (IR)‐induced mouse kidneys, as well as in IR‐induced human renal cortical tubular epithelial (RCTE) cells through proteasome‐mediated degradation. Inhibition of EZH2 with its specific inhibitor 3‐DZNeP promotes tubular cell senescence and kidney aging characterized by an increase in the expression of senescence markers, including p16 and p21, in mouse kidneys and in IR‐induced RCTE cells. We show that EZH2 represses the transcription of p16 through trimethylation of H3K27me3, which directly binds to the promoter of p16. EZH2 represses the transcription of p21 through directly binding to the promoter of p21, and this process is involved in its interaction with p53 and its phosphorylation by ataxia‐telangiectasia mutated (ATM), a critical protein involved in the cellular response to DNA damage. Inhibition of ATM with its inhibitor decreased the phosphorylation of EZH2 and the binding of EZH2 to the promoter of p21 in IR‐treated RCTE cells in a p53‐dependent manner. This study suggests that EZH2 plays a critical role in preventing kidney aging and DNA‐damage‐induced renal tubular cellular senescence, in which senescence and kidney aging also result in the destabilization of EZH2, forming a negative feedback loop.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Nephrology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Yingying Zhang, Chen Yu
Förderung
- NIDDK NIH HHS
- NHGRI NIH HHS
- DOD | AF | ATC | 59th Medical Wing (MDW)
- All of Us Research Program
- 59th Medical Wing
Zitieren
APA
Zhang, Y., Yu, C., Agborbesong, E., & Li, X. (2025). Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging. The FASEB Journal. https://doi.org/10.1096/fj.202500128r
Vancouver
Zhang Y, Yu C, Agborbesong E, Li X. Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging. The FASEB Journal. 2025. doi:10.1096/fj.202500128r
BibTeX
@article{Zhang2025,
author = {Zhang, Yingying and Yu, Chen and Agborbesong, Ewud and Li, Xiaogang},
title = {Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500128r}
}
EUVIMED